Definitive Contract 75F40125C00095
Award Date
9/23/25
Potential Completion Date
9/29/28
Potential Value
$3.1M
Federal Agency
Food and Drug Administration
Awardee
DNA Hive LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Rockville, MD 20853, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $515,769.89 firm fixed price definitive contract to the University of St. Gallen, a Swiss educational institution, to conduct research and develop tools to strengthen post-market surveillance of FDA-regulated products. The objective is to apply advanced analytics and hybrid artificial intelligence to improve risk identification. This contract was awarded under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research...
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the FDA's...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
Landrau Scientific Innovations LLC was awarded a $567,980 firm fixed price definitive contract by the Department of Health and Human Services Food and Drug Administration to support the agency's Broad Agency Announcement PMQWP#237. This BAA seeks advanced research and development proposals to evaluate critical process parameters for the preparation of amphotericin B that influence toxicity, advancing the FDA's regulatory science and innovation goals. The prime contractor will conduct work at its...
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
This is a $90,624.80 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Adaptive Biotechnologies Corporation (Adaptive) for the provision of Adaptive Biotechnologies kits. The contract has a completion date of October 30, 2020. Adaptive is a commercial provider of immune-driven medicine services and products, and this award supports the company's provision of specialized testing and genomic sequencing services to the FDA. The...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,275,361.26 definitive cost-no-fee contract to Alliance Nctn Foundation, a non-profit organization and foundation, to conduct the "Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Data Capture and Standardization Study". This contract, with a performance period ending on September 29, 2024, is part of the FDA's broader efforts to advance regulatory science and support public...
The Department of Health and Human Services Food and Drug Administration awarded a $2.3 million delivery order contract to Dnanexus, Inc. for Increment B of PrecisionFDA. Dnanexus will provide labor hours to further develop PrecisionFDA, an FDA initiative that applies bioinformatics and computational biology to regulatory science. The one-year contract was awarded on September 16, 2020 and has a period of performance through September 29, 2021. Work will be conducted by Dnanexus at its...
Yale University was awarded a definitive cost-no-fee contract valued at $3.3 million by the Department of Health and Human Services Food and Drug Administration to support the agency's Broad Agency Announcement for Advanced Research and Development of Regulatory Science. The prime contractor will leverage community engagement and electronic health record strategies to promote diverse participation in COVID-19 clinical trials, addressing Research Area 9 under the BAA which seeks proposals to...
This is a $1,085,530 definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Genentech Inc., a foreign-owned for-profit organization, to conduct basic and applied research and development to support regulatory science and innovation. The contract is a result of the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science, which is an agency-wide effort to advance scientific knowledge in specific...